Shahram Hedjazifar

2.3k total citations · 1 hit paper
22 papers, 1.8k citations indexed

About

Shahram Hedjazifar is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Shahram Hedjazifar has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 10 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Shahram Hedjazifar's work include Adipose Tissue and Metabolism (14 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers) and Cardiovascular Disease and Adiposity (5 papers). Shahram Hedjazifar is often cited by papers focused on Adipose Tissue and Metabolism (14 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers) and Cardiovascular Disease and Adiposity (5 papers). Shahram Hedjazifar collaborates with scholars based in Sweden, Spain and Finland. Shahram Hedjazifar's co-authors include Ulf Smith, Ann Hammarstedt, Birgit Gustafson, Silvia Gogg, Annika Nerstedt, Lachmi Jenndahl, John Grünberg, Jenny Hoffmann, Cristina M. Rondinone and Joseph Grimsby and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Physiological Reviews.

In The Last Decade

Shahram Hedjazifar

22 papers receiving 1.7k citations

Hit Papers

Impaired Adipogenesis and Dysfunctional Adipose Tissue in... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shahram Hedjazifar Sweden 16 961 755 672 326 168 22 1.8k
Silvia Gogg Sweden 13 935 1.0× 738 1.0× 671 1.0× 269 0.8× 149 0.9× 18 1.7k
Eva Klimčáková France 27 1.3k 1.3× 898 1.2× 645 1.0× 392 1.2× 147 0.9× 37 2.1k
Alexandra L. Ghaben United States 9 901 0.9× 748 1.0× 826 1.2× 279 0.9× 123 0.7× 10 1.8k
Lavanya Vishvanath United States 19 1.5k 1.6× 1.1k 1.4× 570 0.8× 431 1.3× 165 1.0× 23 2.1k
Thomas S. Morley United States 12 921 1.0× 805 1.1× 531 0.8× 322 1.0× 203 1.2× 17 1.8k
K Röhrig Germany 18 784 0.8× 845 1.1× 554 0.8× 224 0.7× 272 1.6× 25 1.7k
Sylvie Franckhauser Spain 20 740 0.8× 449 0.6× 599 0.9× 175 0.5× 197 1.2× 28 1.4k
Naomi Hosogai Japan 8 690 0.7× 592 0.8× 344 0.5× 256 0.8× 110 0.7× 11 1.2k
Agnès Pernin Switzerland 13 811 0.8× 733 1.0× 818 1.2× 379 1.2× 252 1.5× 16 2.0k
Hiroyuki Mori United States 15 610 0.6× 407 0.5× 619 0.9× 125 0.4× 239 1.4× 23 1.6k

Countries citing papers authored by Shahram Hedjazifar

Since Specialization
Citations

This map shows the geographic impact of Shahram Hedjazifar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shahram Hedjazifar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shahram Hedjazifar more than expected).

Fields of papers citing papers by Shahram Hedjazifar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shahram Hedjazifar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shahram Hedjazifar. The network helps show where Shahram Hedjazifar may publish in the future.

Co-authorship network of co-authors of Shahram Hedjazifar

This figure shows the co-authorship network connecting the top 25 collaborators of Shahram Hedjazifar. A scholar is included among the top collaborators of Shahram Hedjazifar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shahram Hedjazifar. Shahram Hedjazifar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hoffmann, Jenny, Shahram Hedjazifar, L Bonnet, et al.. (2021). Adult mice are unresponsive to AAV8-Gremlin1 gene therapy targeting the liver. PLoS ONE. 16(2). e0247300–e0247300. 1 indexed citations
3.
Erlandsson, Malin C., Shahram Hedjazifar, Rille Pullerits, et al.. (2021). Impact of the Uncoupling Protein 1 on Cardiovascular Risk in Patients with Rheumatoid Arthritis. Cells. 10(5). 1131–1131. 4 indexed citations
4.
Hedjazifar, Shahram, Ann Hammarstedt, L Bonnet, et al.. (2019). The Novel Adipokine Gremlin 1 Antagonizes Insulin Action and Is Increased in Type 2 Diabetes and NAFLD/NASH. Diabetes. 69(3). 331–341. 41 indexed citations
5.
Hoffmann, Jenny, John Grünberg, Ann Hammarstedt, et al.. (2019). BMP4 gene therapy enhances insulin sensitivity but not adipose tissue browning in obese mice. Molecular Metabolism. 32. 15–26. 19 indexed citations
6.
Ferrannini, Ele, Ritesh K. Baboota, Shahram Hedjazifar, et al.. (2019). Mannose is an insulin-regulated metabolite reflecting whole-body insulin sensitivity in man. Metabolism. 102. 153974–153974. 24 indexed citations
7.
Hammarstedt, Ann, Silvia Gogg, Shahram Hedjazifar, Annika Nerstedt, & Ulf Smith. (2018). Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity. Physiological Reviews. 98(4). 1911–1941. 327 indexed citations breakdown →
8.
Grünberg, John, Jenny Hoffmann, Shahram Hedjazifar, et al.. (2017). Overexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistance. Scientific Reports. 7(1). 26 indexed citations
9.
Hoffmann, Jenny, John Grünberg, Christopher Church, et al.. (2017). BMP4 Gene Therapy in Mature Mice Reduces BAT Activation but Protects from Obesity by Browning Subcutaneous Adipose Tissue. Cell Reports. 20(5). 1038–1049. 61 indexed citations
10.
Longo, Michele, Gregory Alexander Raciti, Federica Zatterale, et al.. (2017). Epigenetic modifications of the Zfp/ZNF423 gene control murine adipogenic commitment and are dysregulated in human hypertrophic obesity. Diabetologia. 61(2). 369–380. 48 indexed citations
11.
Grünberg, John, et al.. (2017). CCN5/WISP2 and metabolic diseases. Journal of Cell Communication and Signaling. 12(1). 309–318. 25 indexed citations
12.
Ohlsson, Claes, Ann Hammarstedt, Liesbeth Vandenput, et al.. (2017). Increased adipose tissue aromatase activity improves insulin sensitivity and reduces adipose tissue inflammation in male mice. American Journal of Physiology-Endocrinology and Metabolism. 313(4). E450–E462. 47 indexed citations
13.
Gustafson, Birgit, Shahram Hedjazifar, Silvia Gogg, Ann Hammarstedt, & Ulf Smith. (2015). Insulin resistance and impaired adipogenesis. Trends in Endocrinology and Metabolism. 26(4). 193–200. 288 indexed citations
14.
Gustafson, Birgit, Ann Hammarstedt, Shahram Hedjazifar, et al.. (2015). BMP4 and BMP Antagonists Regulate Human White and Beige Adipogenesis. Diabetes. 64(5). 1670–1681. 167 indexed citations
15.
Grünberg, John, Ann Hammarstedt, Shahram Hedjazifar, & Ulf Smith. (2014). The Novel Secreted Adipokine WNT1-inducible Signaling Pathway Protein 2 (WISP2) Is a Mesenchymal Cell Activator of Canonical WNT. Journal of Biological Chemistry. 289(10). 6899–6907. 65 indexed citations
16.
Gustafson, Birgit, Ann Hammarstedt, Shahram Hedjazifar, & Ulf Smith. (2013). Restricted Adipogenesis in Hypertrophic Obesity. Diabetes. 62(9). 2997–3004. 119 indexed citations
17.
Gustafson, Birgit, Silvia Gogg, Shahram Hedjazifar, et al.. (2009). Inflammation and impaired adipogenesis in hypertrophic obesity in man. American Journal of Physiology-Endocrinology and Metabolism. 297(5). E999–E1003. 238 indexed citations
18.
Andersson, Christian X., Birgit Gustafson, Ann Hammarstedt, Shahram Hedjazifar, & Ulf Smith. (2008). Inflamed adipose tissue, insulin resistance and vascular injury. Diabetes/Metabolism Research and Reviews. 24(8). 595–603. 90 indexed citations
19.
Hedjazifar, Shahram, Lachmi Jenndahl, Hiroaki Shimokawa, & Dan Baeckström. (2005). PKB mediates c-erbB2-induced epithelial β1 integrin conformational inactivation through Rho-independent F-actin rearrangements. Experimental Cell Research. 307(1). 259–275. 7 indexed citations
20.
Hedjazifar, Shahram, et al.. (2002). c-erbB2–induced Disruption of Matrix Adhesion and Morphogenesis Reveals a Novel Role for Protein Kinase B as a Negative Regulator of α2β1Integrin Function. Molecular Biology of the Cell. 13(8). 2894–2908. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026